Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort study
H2020 European Research Council, Novartis Pharmacy B V Oncology Europe, Amgen, BMS/Celgene International, Janssen Pharmaceutica, Takeda Pharmaceuticals International, and Gilead Sciences.
Authors
- Laurence Sanhès (ORCID: https://orcid.org/0000-0003-1207-7665)
- David Bowen (ORCID: https://orcid.org/0000-0003-2294-2544)
- Pierre Fenaux (ORCID: https://orcid.org/0000-0002-0468-3553)
- Ιoannis Kotsianidis (ORCID: https://orcid.org/0000-0001-7668-0186)
- Corine van Marrewijk (ORCID: https://orcid.org/0000-0002-9547-908X)
- Dominic Culligan (ORCID: https://orcid.org/0000-0002-4172-4051)
- Karin A. Koinig (ORCID: https://orcid.org/0000-0002-3659-4934)
- Argiris Symeonidis (ORCID: https://orcid.org/0000-0002-3685-3473)
- Simon Crouch (ORCID: https://orcid.org/0000-0002-3026-2859)
- Maud D’Aveni (ORCID: https://orcid.org/0000-0002-5909-2742)
- Eva Hellström‐Lindberg (ORCID: https://orcid.org/0000-0002-7839-3743)
- Timothy Bagguley (ORCID: https://orcid.org/0000-0002-6150-3467)
- Guillermo Sanz (ORCID: https://orcid.org/0000-0002-2767-8191)
- Moshe Mittelmann
- Ulrich Germing
- Luca Malcovati (ORCID: https://orcid.org/0000-0002-1460-1611)
- Saskia Langemeijer (ORCID: https://orcid.org/0000-0002-0366-0800)
- Reinhard Stauder (ORCID: https://orcid.org/0000-0002-8993-9561)
- Jaroslav Čermák (ORCID: https://orcid.org/0009-0006-0961-3294)
- Alexandra Smith (ORCID: https://orcid.org/0000-0002-6168-4384)
- Adele Taylor
- Theo deWitte
- Hege Kristin Gravdahl Garelius
Institutions
- Innsbruck Medical University (AT)
- Radboud University Nijmegen (NL)
- University of Patras (GR)
- University of Pavia (IT)
- Leeds Teaching Hospitals NHS Trust (GB)
- Tel Aviv Sourasky Medical Center (IL)
- Aberdeen Royal Infirmary (GB)
- Sahlgrenska University Hospital (SE)
- Radboud University Medical Center (NL)
- Karolinska Institutet (SE)
- Düsseldorf University Hospital (DE)
- Centre Hospitalier de Perpignan (FR)
- Institute of Haematology and Blood Transfusion (CZ)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- UMIT - Private Universität für Gesundheitswissenschaften, Medizinische Informatik und Technik (AT)
- Hospital General Universitario De Valencia (ES)
- Hôpital Saint-Louis (FR)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- University Hospital of Alexandroupolis (GR)
- Heinrich Heine University Düsseldorf (DE)
- University of York (GB)
Publication Details
- Journal
- The Lancet Haematology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1016/s2352-3026(24)00350-8
- Citations
- 3
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 5.31
Funders
- Amgen
- Bristol-Myers Squibb
- Gilead Sciences
- Celgene
- European Commission
- National Institutes of Health
- Horizon 2020 Framework Programme
- Takeda Pharmaceuticals International